Empowering Kinase Drug Discovery: Unleashing the Potential of Tyrosine Phosphoproteomics
Time: 10:00 am
day: Conference Day Two
Details:
- Revolutionizing kinase profiling with SH2-superbinder technology
- Unveiling and overcoming resistance mechanisms to KRAS-G12C and BTK inhibitors
- Integrating phosphotyrosine and TPD proteomics for comprehensive insights
